- SME BUSINESS REVIEW

DEVELOPMENTS

Beyond the Care Cliff: How Neuro20 Technologies is Reimagining the Future of Neurological Rehabilitation

Our mission has never been to replace therapists, but to help extend their reach.

July 25, 2026 • By Donna Joseph

Teva Launches Rise, Taps Startups for Pharma Innovation

Nov. 19, 2025 • By Donna Joseph

Merck to Acquire Cidara Therapeutics for $9.2 Billion in a Strategic Flu Prevention Initiative

Nov. 14, 2025 • By Donna Joseph

UnitedHealth Banks on New Leadership to Regain Momentum

With a familiar leader back at the helm and a well-laid plan in place, UnitedHealth is working to steady its operations...

Oct. 27, 2025 • By Donna Joseph

Just In: Boston Scientific Acquires Nalu Medical for $533 Million

The acquisition brings a novel neurostimulation device into Boston Scientific’s portfolio, expanding its capacity to pro...

Oct. 17, 2025 • By Donna Joseph

Baxdrostat Breakthrough Offers New Hope for Resistant Hypertension

AstraZeneca’s Bax24 Phase III trial demonstrates sustained blood pressure control and a favorable safety profile in pati...

Oct. 8, 2025 • By Donna Joseph

UnitedHealth Scales Back Medicare Advantage Plans in 16 Counties Amid Rising Program Costs and Funding Cuts

Industry analysts warn the move could signal broader consolidation and narrower choices for members in rural areas.

Oct. 1, 2025 • By Donna Joseph

Novo Nordisk Freezes Hiring as Costs Rise Despite Wegovy FDA Approval

Aug. 21, 2025 • By Donna Joseph

Spurt in Road Accidents Makes Advanced Critical Care Crucial to Save Victims in ‘Golden Hour’

July 25, 2025 • By Donna Joseph

Sword Health Raises $40M, Pushes IPO to 2028 as Growth Strategy Shifts

June 17, 2025 • By Donna Joseph

AstraZeneca Deepens China Ties With $5.3 Billion CSPC AI Research Deal

June 16, 2025 • By Donna Joseph

Novo Nordisk Ousts CEO as U.S. Rivals Gain Ground, Drug Pipeline Disappoints

Denmark’s pharmaceutical giant navigates leadership shake-up after Wegovy sales falter and investor confidence wanes.

May 16, 2025 • By Donna Joseph

Novo Nordisk Ousts CEO as U.S. Rivals Gain Ground, Drug Pipeline Disappoints

Eli Lilly’s Zepbound Outperforms Novo Nordisk’s Wegovy in Head-to-Head Weight-Loss Trial

May 12, 2025 • By Donna Joseph

Novo Nordisk Cuts Sales Forecast Amid U.S. Slowdown, Expects Wegovy Recovery After FDA Crackdown

May 7, 2025 • By Donna Joseph

U.S. Pledges $500 Million to Develop Universal Vaccines

May 1, 2025 • By Donna Joseph

Roche to Invest $50 Billion in U.S., Add 12,000 Jobs as Trade Challenges Mount

April 22, 2025 • By Donna Joseph

With These Funds We can Advance our Platform, Crucially Developing a Service for Children, Young People and their Families and Carers, Expanding our Reach so More People are Able to Get Help Sooner: Dr Melinda Rees

June 8, 2024 • By Donna Joseph

Toon Overbeeke, CEO & Co-Founder of Vitestro

LATEST IN FINANCIAL LITERACY

Content provided by finlittoday.com

Jonathan V. Gould Details OCC’s Financial Literacy Efforts as Banking Services Evolve

Healthcare & MedTech

Beyond the Care Cliff: How Neuro20 Technologies is Reimagining the Future of Neurological Rehabilitation

Teva Launches Rise, Taps Startups for Pharma Innovation

Merck to Acquire Cidara Therapeutics for $9.2 Billion in a Strategic Flu Prevention Initiative

UnitedHealth Banks on New Leadership to Regain Momentum

Just In: Boston Scientific Acquires Nalu Medical for $533 Million

Baxdrostat Breakthrough Offers New Hope for Resistant Hypertension

UnitedHealth Scales Back Medicare Advantage Plans in 16 Counties Amid Rising Program Costs and Funding Cuts

Novo Nordisk Freezes Hiring as Costs Rise Despite Wegovy FDA Approval

Spurt in Road Accidents Makes Advanced Critical Care Crucial to Save Victims in ‘Golden Hour’

Sword Health Raises $40M, Pushes IPO to 2028 as Growth Strategy Shifts

AstraZeneca Deepens China Ties With $5.3 Billion CSPC AI Research Deal

Novo Nordisk Ousts CEO as U.S. Rivals Gain Ground, Drug Pipeline Disappoints

Eli Lilly’s Zepbound Outperforms Novo Nordisk’s Wegovy in Head-to-Head Weight-Loss Trial

Novo Nordisk Cuts Sales Forecast Amid U.S. Slowdown, Expects Wegovy Recovery After FDA Crackdown

U.S. Pledges $500 Million to Develop Universal Vaccines

Roche to Invest $50 Billion in U.S., Add 12,000 Jobs as Trade Challenges Mount

With These Funds We can Advance our Platform, Crucially Developing a Service for Children, Young People and their Families and Carers, Expanding our Reach so More People are Able to Get Help Sooner: Dr Melinda Rees

Vitestro Attracts $22M Funding to Revolutionize Healthcare with Autonomous Blood Drawing Technology

MedTech's Surge: How Innovation is Transforming Patient Care

HHP Enters New Phase of Growth, Promotes Meg Finn to VP of Marketing

Code Blue to Digital Hue: The Reshaping of Healthcare by Health Tech

LATEST IN FINANCIAL LITERACY

Jonathan V. Gould Details OCC’s Financial Literacy Efforts as Banking Services Evolve

How Heartland Bank and Trust Builds on Generations of Trust and Service

What Students Learned About Money Management at Mississippi Charities’ Back-to-School Fair

Gráinne Griffin Appointed Ireland’s Financial Literacy Ambassador

How Paramount Pictures Monetizes Films, Franchises, and Intellectual Property

How The Walt Disney Company Generates Billions Across Entertainment, Streaming, and Experiences

Universal Studios’ Century-Long Evolution from Film Industry Pioneer to Global Entertainment Powerhouse

Christopher Nolan is One of Cinema’s Most Valuable Creative Assets

Healthcare & MedTech

LATEST IN FINANCIAL LITERACY

Subscribe to Our Weekly Newsletter